IRS Logo
Print - Click this link to Print this page

Qualifying Therapeutic Discovery Project Grants for the State of Alabama

The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.

The project descriptions below were extracted from the applicant certification forms as submitted.

Alabama $ 3,708,304.65
Applicant Name Project Name Grants Awarded for 2009 Grants Awarded for 2010
Agenta Biotechnologies Inc Molecular Heparan Sulfate Delivery in Barrier Membranes and Soft Tissue Wound Closure $ 59,614.76 $ 184,864.48
AGENTA BIOTECHNOLOGIES INC DELIVERY OF GROWTH-FACTOR CO-RECEPTOR HEPARAN SULFATE IN BONE GRAFT SUBSTITUTES FOR REPAIR $ 169,808.39 $ 6,666.50
BioCryst Pharmaceuticals Inc BCX4208 for Treatment of Gout $ 244,479.25  
BioCryst Pharmaceuticals, Inc Peramivir  for Treatment of Influenza $ 244,479.25  
BioCryst Pharmaceuticals, Inc Forodesine for Treatment of CLL and CTCL $ 244,479.25  
BioCryst Pharmaceuticals, Inc. BCX4161 for Treatment of Hereditary Angioedema   $ 86,380.89
BioCryst Pharmceuticals, Inc. JAK Inhibitors for Treatment of Psoriasis, Ankylosing Spondylitis, & Multiple Sclerosis $ 244,479.25  
Diatherix Laboratories, Inc. Disease Diagnostic Panel Development Utilizing the TEM-PCR Method $ 244,479.25  
EGEN INC EGEN-001 in Platinum-Resistant Ovarian Cancer $ 244,479.25  
EGEN, INC. EGEN TheraSilence $ 244,479.25  
iCubate, Inc Development of an Apparatus for Performing am-PCR $ 244,479.25  
PNP Therapeutics Inc Phase 1, Open-label Syudy Evaluting the Safety of Escalating Doses of Ad/PNP-F-araAMP $ 244,479.25  
Serina Therapeutics, Inc SER-201 for the treatment of colorectal and ovarian cancer $ 244,479.25  
Vaxin Inc. Development of an Adenovirus-Vectored Nasal Anthrax Vaccine $ 244,479.25  
Vaxin Inc. Replication-Defective Adenovirus-Vectored Influenza Vaccine Development $ 161,175.00 $ 83,304.25
Vista Engineering Inc Nanotechnology Enabled Temporomandibular Joint (TMJ) Prosthesis $ 29,059.63 $ 32,059.00
Volatile Analysis Corporation Development of sorptive nasal stent for diagnostic biomarker detection $ 23,600.00 $ 182,500.00

Rate the Small Business and Self-Employed Website

Page Last Reviewed or Updated: 15-Oct-2014